President Trump announced a deal with pharmaceutical companies Novo Nordisk and Eli Lilly to lower the cost of popular weight‑loss drugs. Medications such as Wegovy and Zepbound, which have often cost consumers more than $1,000 a month, will drop to about $350 for a one‑month supply under the agreement.

See Full Page